临床生物统计学。28. 药物监测的生物统计学问题。 - Suppr

Suppr

超能文献

Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.

作者信息

Feinstein A R

出版信息

Clin Pharmacol Ther. 1974 Jul;16(1):110-23. doi: 10.1002/cpt1974161part1110.

DOI:10.1002/cpt1974161part1110

PMID:4843239

Abstract

摘要

相似文献

Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.

Clin Pharmacol Ther. 1974 Jul;16(1):110-23. doi: 10.1002/cpt1974161part1110.

Adverse drug reactions: the need for detection and control.

Am J Epidemiol. 1971 Nov;94(5):405-8. doi: 10.1093/oxfordjournals.aje.a121336.

Monitoring adverse reactions to drugs: toward a therapeutic audit.

Int J Health Serv. 1974 Winter;4(1):109-23. doi: 10.2190/D2G5-DW5J-F9JH-PHKT.

Methods of monitoring adverse reactions to drugs.

Prog Drug Res. 1977;21:231-92. doi: 10.1007/978-3-0348-7098-6_3.

Clinical biostatistics. XXX. Biostatistical problems in 'compliance bias'.

Clin Pharmacol Ther. 1974 Nov;16(5 Part 1):846-57. doi: 10.1002/cpt1974165part1846.

Panel 4: phase IV investigations.

Clin Pharmacol Ther. 1975 Nov;18(5 Pt 2):653-6. doi: 10.1002/cpt1975185part2653.

Towards rational drug therapy in old age. The F.E. Williams Lecture 1985.

J R Coll Physicians Lond. 1985 Oct;19(4):235-9.

The rationale for a post-marketing surveillance.

Hum Reprod. 1987 Jan;2(1):41-4. doi: 10.1093/oxfordjournals.humrep.a136486.

Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.

BMJ. 2016 Oct 3;355:i5078. doi: 10.1136/bmj.i5078.

Biostatistical perspectives in the epidemiology of narcotic abuse.

Ann N Y Acad Sci. 1978;311:25-34. doi: 10.1111/j.1749-6632.1978.tb16760.x.

引用本文的文献

A new approach to identify, classify and count drug-related events.

Br J Clin Pharmacol. 2013 Sep;76 Suppl 1(Suppl 1):56-68. doi: 10.1111/bcp.12189.

Toward reducing the ambiguity of adverse drug reactions: a computerized system.

J Med Syst. 1982 Feb;6(1):23-39. doi: 10.1007/BF00994118.

Difficulties in assessing the adverse effects of drugs.

Br J Clin Pharmacol. 1981;11 Suppl 1(Suppl 1):105S-110S. doi: 10.1111/j.1365-2125.1981.tb01845.x.

Reversible hepatotoxicity related to amphotericin B.

Can Med Assoc J. 1984 Nov 15;131(10):1245-7.

Assessment of adverse drug reactions in psychiatric hospitals.

Eur J Clin Pharmacol. 1984;26(6):727-34. doi: 10.1007/BF00541933.

Diagnosis of acute drug-induced liver injury. Usefulness of clinicopathological patterns and biochemical indices.

Med Toxicol. 1986 Mar-Apr;1(2):77-82. doi: 10.1007/BF03259829.

Evaluation of safety and tolerance in clinical trials with antimicrobial agents.

Eur J Clin Microbiol Infect Dis. 1990 Jul;9(7):530-3. doi: 10.1007/BF01964297.

Teaching monograph. Tissue reactions to drugs.

Am J Pathol. 1976 Mar;82(3):613-47.

Methodology and results of a survey of adverse reactons to a drug in private practice.

Eur J Clin Pharmacol. 1977 Mar 11;11(3):181-92. doi: 10.1007/BF00606408.

The ambiguity of adverse drug reactions.

Eur J Clin Pharmacol. 1977 Jan 3;11(2):75-8. doi: 10.1007/BF00562895.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.

Clin Pharmacol Ther. 1974 Jul;16(1):110-23. doi: 10.1002/cpt1974161part1110.

Adverse drug reactions: the need for detection and control.

Am J Epidemiol. 1971 Nov;94(5):405-8. doi: 10.1093/oxfordjournals.aje.a121336.

Monitoring adverse reactions to drugs: toward a therapeutic audit.

Int J Health Serv. 1974 Winter;4(1):109-23. doi: 10.2190/D2G5-DW5J-F9JH-PHKT.

Methods of monitoring adverse reactions to drugs.

Prog Drug Res. 1977;21:231-92. doi: 10.1007/978-3-0348-7098-6_3.

Clinical biostatistics. XXX. Biostatistical problems in 'compliance bias'.

Clin Pharmacol Ther. 1974 Nov;16(5 Part 1):846-57. doi: 10.1002/cpt1974165part1846.

Panel 4: phase IV investigations.

Clin Pharmacol Ther. 1975 Nov;18(5 Pt 2):653-6. doi: 10.1002/cpt1975185part2653.

Towards rational drug therapy in old age. The F.E. Williams Lecture 1985.

J R Coll Physicians Lond. 1985 Oct;19(4):235-9.

The rationale for a post-marketing surveillance.

Hum Reprod. 1987 Jan;2(1):41-4. doi: 10.1093/oxfordjournals.humrep.a136486.

Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.

BMJ. 2016 Oct 3;355:i5078. doi: 10.1136/bmj.i5078.

Biostatistical perspectives in the epidemiology of narcotic abuse.

Ann N Y Acad Sci. 1978;311:25-34. doi: 10.1111/j.1749-6632.1978.tb16760.x.

引用本文的文献

A new approach to identify, classify and count drug-related events.

Br J Clin Pharmacol. 2013 Sep;76 Suppl 1(Suppl 1):56-68. doi: 10.1111/bcp.12189.

Toward reducing the ambiguity of adverse drug reactions: a computerized system.

J Med Syst. 1982 Feb;6(1):23-39. doi: 10.1007/BF00994118.

Difficulties in assessing the adverse effects of drugs.

Br J Clin Pharmacol. 1981;11 Suppl 1(Suppl 1):105S-110S. doi: 10.1111/j.1365-2125.1981.tb01845.x.

Reversible hepatotoxicity related to amphotericin B.

Can Med Assoc J. 1984 Nov 15;131(10):1245-7.

Assessment of adverse drug reactions in psychiatric hospitals.

Eur J Clin Pharmacol. 1984;26(6):727-34. doi: 10.1007/BF00541933.

Diagnosis of acute drug-induced liver injury. Usefulness of clinicopathological patterns and biochemical indices.

Med Toxicol. 1986 Mar-Apr;1(2):77-82. doi: 10.1007/BF03259829.

Evaluation of safety and tolerance in clinical trials with antimicrobial agents.

Eur J Clin Microbiol Infect Dis. 1990 Jul;9(7):530-3. doi: 10.1007/BF01964297.

Teaching monograph. Tissue reactions to drugs.

Am J Pathol. 1976 Mar;82(3):613-47.

Methodology and results of a survey of adverse reactons to a drug in private practice.

Eur J Clin Pharmacol. 1977 Mar 11;11(3):181-92. doi: 10.1007/BF00606408.

The ambiguity of adverse drug reactions.

Eur J Clin Pharmacol. 1977 Jan 3;11(2):75-8. doi: 10.1007/BF00562895.